{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:25:25Z","timestamp":1773923125530,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,11,15]],"date-time":"2014-11-15T00:00:00Z","timestamp":1416009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s12094-014-1251-1","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T22:49:23Z","timestamp":1416005363000},"page":"409-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience"],"prefix":"10.1007","volume":"17","author":[{"given":"H.","family":"Al-Husaini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Soudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Eltigani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Edesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Elhassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Elghamry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Al-Hashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Al-Hayli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Madkhali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. A.","family":"Al-Badawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,15]]},"reference":[{"issue":"9742","key":"1251_CR1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(10)60280-2","volume":"376","author":"MJ Seckl","year":"2010","unstructured":"Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717\u201329.","journal-title":"Lancet"},{"key":"1251_CR2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/01.AOG.0000224697.31138.a1","volume":"108","author":"JT Soper","year":"2006","unstructured":"Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108:176\u201387.","journal-title":"Obstet Gynecol"},{"key":"1251_CR3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9378(11)80033-5","volume":"164","author":"JR Lurain","year":"1991","unstructured":"Lurain JR, Casanova LA, Miller DS, Rademaker AW. Prognostic factors in gestational trophoblastic tumors: A proposed new scoring system based on multivariate analysis. Am J Obstet Gynecol. 1991;164:611\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"1251_CR4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(03)90120-2","volume":"83","author":"HY Ngan","year":"2003","unstructured":"Ngan HY, Bender H, Benedet JL, Jones H, Montruccoli GC, Pecorelli S. FIGO Committee on Gynecologic Oncology. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int J Gynaecol Obstet. 2003;83(Suppl 1):175\u20137.","journal-title":"Int J Gynaecol Obstet"},{"key":"1251_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0090-8258(86)90123-X","volume":"23","author":"RS Berkowitz","year":"1986","unstructured":"Berkowitz RS, Goldstein DP, Bernstein MR. Ten years\u2019 experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol. 1986;23:111\u20138.","journal-title":"Gynecol Oncol"},{"key":"1251_CR6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCO.0b013e3282dc94e5","volume":"19","author":"S Ngan","year":"2007","unstructured":"Ngan S, Seckl MJ. Gestational trophoblastic neoplasia management: An update. Curr Opin Oncol. 2007;19:486\u201391.","journal-title":"Curr Opin Oncol"},{"key":"1251_CR7","first-page":"875","volume":"51","author":"BK Chakrabarti","year":"2006","unstructured":"Chakrabarti BK, Mondal NR, Chatterjee T. Gestational trophoblastic tumor at a tertiary level cancer center: A retrospective study. J Reprod Med. 2006;51:875\u20138.","journal-title":"J Reprod Med"},{"key":"1251_CR8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ygyno.2006.05.011","volume":"103","author":"CA Lok","year":"2006","unstructured":"Lok CA, Ansink AC, Grootfaam D, van der Velden J, Verheijen RH, ten Kate-Booij MJ. Treatment and prognosis of post term choriocarcinoma in The Netherlands. Gynecol Oncol. 2006;103:698\u2013702.","journal-title":"Gynecol Oncol"},{"key":"1251_CR9","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1525-1438.2006.00592.x","volume":"16","author":"IK El-Lamie","year":"2006","unstructured":"El-Lamie IK, El Sayed HM, Badawie AG, Bayomi WA, El-Ghazaly HA, Khalaf-Allah AE, et al. Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience. Int J Gynecol Cancer. 2006;16:866\u201374.","journal-title":"Int J Gynecol Cancer"},{"key":"1251_CR10","doi-asserted-by":"crossref","unstructured":"Osborne RJ, Filiaci V, Schink JC, Mannel RS, Alvarez Secord A, Kelley JL, et al. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: A Gynecologic Oncology Group study. J Clin Oncol. 2011;29:825-31.","DOI":"10.1200\/JCO.2010.30.4386"},{"key":"1251_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000009987","volume":"46","author":"H Matsui","year":"1998","unstructured":"Matsui H, Iitsuka Y, Seki K, Sekiya S. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease: Remission rates and drug toxicities. Gynecol Obstet Invest. 1998;46:5\u20138.","journal-title":"Gynecol Obstet Invest"},{"key":"1251_CR12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1471-0528.1991.tb10369.x","volume":"98","author":"ES Newlands","year":"1991","unstructured":"Newlands ES, Bagshawe KD, Begent RH, Rustin GJ, Holden L. Results with the EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high-risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol. 1991;98:550\u20137.","journal-title":"Br J Obstet Gynaecol"},{"key":"1251_CR13","first-page":"767","volume":"51","author":"JR Lurain","year":"2006","unstructured":"Lurain JR, Singh DK, Schink JC. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med. 2006;51:767\u201372.","journal-title":"J Reprod Med"},{"key":"1251_CR14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2003.08.028","volume":"91","author":"PF Escobar","year":"2003","unstructured":"Escobar PF, Lurain JR, Singh DK, Bozorgi K, Fishman DA. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Gynecol Oncol. 2003;91:552\u20137.","journal-title":"Gynecol Oncol"},{"key":"1251_CR15","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2012.462","volume":"107","author":"A Sita-Lumsden","year":"2012","unstructured":"Sita-Lumsden A, Short D, Lindsay I, Sebire NJ, Adjogatse D, Seckl MJ, et al. Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000-2009. Br J Cancer. 2012;107:1810\u20134.","journal-title":"Br J Cancer"},{"key":"1251_CR16","first-page":"438","volume":"49","author":"H Matsui","year":"2004","unstructured":"Matsui H, Iitsuka Y, Suzuka K, Yamazawa K, Mitsuhashi A, Sekiya S. Salvage chemotherapy for high-risk gestational trophoblastic tumor. J Reprod Med. 2004;49:438\u201342.","journal-title":"J Reprod Med"},{"key":"1251_CR17","first-page":"193","volume":"22","author":"Loret de Mola JR","year":"1995","unstructured":"Loret de Mola JR. Goldfarb JM. Reproductive performance of patients after gestational trophoblastic disease. Semin Oncol. 1995;22:193\u20137.","journal-title":"Semin Oncol"},{"key":"1251_CR18","first-page":"3","volume":"36","author":"RS Berkowitz","year":"1991","unstructured":"Berkowitz RS, Goldstein DP, Bernstein MR. Reproductive experience after complete and partial molar pregnancy and gestational trophoblastic tumors. J Reprod Med. 1991;36:3\u20138.","journal-title":"J Reprod Med"},{"key":"1251_CR19","doi-asserted-by":"crossref","unstructured":"Roberts JP, Lurain JR. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol. 1996;174:1917\u201323; Discussion 1923\u20134.","DOI":"10.1016\/S0002-9378(96)70229-6"},{"key":"1251_CR20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/AOG.0b013e31817f58ae","volume":"112","author":"AV Hoekstra","year":"2008","unstructured":"Hoekstra AV, Lurain JR, Rademaker AW, Schink JC. Gestational trophoblastic neoplasia: Treatment outcomes. Obstet Gynecol. 2008;112:251\u20138.","journal-title":"Obstet Gynecol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1251-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-014-1251-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-014-1251-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T11:49:57Z","timestamp":1566042597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-014-1251-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,15]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1007\/s12094-014-1251-1","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,15]]}}}